Center for Comprehensive Venous Care, Harrington Heart and Vascular Institute, Division of Vascular Surgery and Endovascular Surgery, University Hospitals Cleveland Medical Center, Cleveland, OH.
MedStar Health Vein Centers, Department of Vascular Surgery, MedStar Washington Hospital Center, Washington, DC.
Semin Vasc Surg. 2024 Jun;37(2):156-163. doi: 10.1053/j.semvascsurg.2024.05.006. Epub 2024 Jun 12.
In the past decade, technologies to treat venous pathologies have increased dramatically, to the benefit of an often underserved and overlooked population of patients with venous disease. However, given the rapid release of various technologies, including venous-dedicated stents and thrombectomy devices across varied venous pathologies, evidence-based guidelines have been slow to develop. When discussing appropriateness of care, one needs to consider optimal patient selection, technical approach, medical management, and surveillance protocols, to name a few. All of which, in the venous space, are currently widely varied in practice. The future of deep venous work is limitless, but multicenter, randomized controlled trials are needed to optimally treat patients with venous disease.
在过去的十年中，治疗静脉疾病的技术有了显著的发展，这使静脉疾病患者这一经常被忽视和服务不足的人群受益。然而，鉴于各种技术（包括专门用于静脉的支架和血栓切除术设备）的快速推出，基于证据的指南的发展一直较为缓慢。在讨论护理的适宜性时，需要考虑到最佳的患者选择、技术方法、医疗管理和监测方案等因素。而所有这些在静脉领域的实践中目前都存在很大差异。深静脉工作的未来是无限的，但需要进行多中心、随机对照试验，以优化静脉疾病患者的治疗。
